Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4).
Vanadate (sodium orthovanadate), an inhibitor of phosphotyrosine phosphatases (PTPs), mimics many of the metabolic actions of insulin in vitro and in vivo. The potential of vanadate to stimulate glucose transport independent of the early steps in insulin signaling prompted us to test its effectiveness in an in vitro model of insulin resistance. In primary rat adipocytes cultured for 18 h in the presence of high glucose (15 mm) and insulin (10(-7) m), sensitivity to insulin-stimulated glucose transport was decreased. In contrast, there was a paradoxical enhanced sensitivity to vanadate of the insulin-resistant cells (EC(50) for control, 325 +/- 7.5 microm; EC(50) for insulin-resistant, 171 +/- 32 microm; p < 0.002). Enhanced sensitivity was also present for vanadate stimulation of insulin receptor kinase activity and autophosphorylation and Akt/protein kinase B Ser-473 phosphorylation consistent with more effective PTP inhibition in the resistant cells. Investigation of this phenomenon revealed that 1) depletion of GSH with buthionine sulfoximine reproduced the enhanced sensitivity to vanadate while preincubation of resistant cells with N-acetylcysteine (NAC) prevented it, 2) intracellular GSH was decreased in resistant cells and normalized by NAC, 3) exposure to high glucose and insulin induced an increase in reactive oxygen species, which was prevented by NAC, 4) EPR (electron paramagnetic resonance) spectroscopy showed a decreased amount of vanadyl (+4) in resistant and buthionine sulfoximine-treated cells, which correlated with decreased GSH and increased vanadate sensitivity, while total vanadium uptake was not altered, and 5) inhibition of recombinant PTP1B in vitro was more sensitive to vanadate (+5) than vanadyl (+4). In conclusion, the paradoxical increased sensitivity to vanadate in hyperglycemia-induced insulin resistant adipocytes is due to oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). Thus, sensitivity of PTP inhibition and glucose transport to vanadate is regulated by cellular redox state.
Lu
B
B
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Ennis
D
D
Lai
R
R
Bogdanovic
E
E
Nikolov
R
R
Salamon
L
L
Fantus
C
C
Le-Tien
H
H
Fantus
I G
IG
D000111:Acetylcysteine / Q000494:pharmacology; D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D004578:Electron Spin Resonance Spectroscopy; D005947:Glucose / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D007333:Insulin Resistance; D008297:Male; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010766:Phosphorylation; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species; D011972:Receptor, Insulin / Q000378:metabolism; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors; D014638:Vanadates / Q000378:metabolism* / Q000494:pharmacology*
D017382:Reactive Oxygen Species; D011994:Recombinant Proteins; D014638:Vanadates; D019328:Buthionine Sulfoximine; D011972:Receptor, Insulin; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases; C516610:Ptpn1 protein, rat; D005978:Glutathione; D005947:Glucose; D000111:Acetylcysteine